MRX Marex Group Ltd IFRS Annual reports only
Security & Commodity Brokers, Dealers, Exchanges & Services · Nasdaq · SEC CIK 1997464 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.02B | $1.59B | $1.24B | $711.10M |
| Interest expense | $760.20M | $538.10M | $470.20M | $165.00M |
| Pretax income | $411.60M | $295.80M | $196.50M | $121.60M |
| Income tax | $103.70M | $77.80M | $55.20M | $23.40M |
| Net income | $293.90M | $204.70M | $128.00M | $91.60M |
| EPS (basic) | 4.12 | 2.96 | 1.94 | 1.39 |
| EPS (diluted) | 3.86 | 2.72 | 1.82 | 1.36 |
| Weighted avg. shares (diluted) | 76.13M | 75.28M | 70.32M | 67.57M |
| Banking | ||||
| Net interest income | $152.60M | $227.10M | $121.60M | $29.40M |
| Balance sheet | ||||
| Cash & equivalents | $2.88B | $2.56B | $1.48B | $910.10M |
| Receivables | $10.99B | $7.55B | $4.79B | $4.69B |
| Current assets | $33.70B | $23.83B | $16.94B | $15.35B |
| PP&E, netmay include right-of-use assets (IFRS) | $34.00M | $20.80M | $16.60M | $11.80M |
| Goodwill | $237.40M | $176.50M | $163.60M | $155.50M |
| Intangibles | $98.00M | $56.50M | $56.00M | $25.60M |
| Total assets | $34.68B | $24.31B | $17.61B | $15.74B |
| Current liabilities | $30.96B | $21.78B | $15.88B | $14.56B |
| Short-term debt | $200.00M | $152.00M | $0 | $12.90M |
| Long-term debt | $0 | $0 | $0 | $135.80M |
| Total debt | $200.00M | $152.00M | $0 | $148.70M |
| Total liabilities | $33.41B | $23.34B | $16.84B | $15.07B |
| Shareholders' equity | $1.17B | $879.30M | $775.90M | $677.70M |
| Net debt | -$2.68B | -$2.40B | -$1.48B | -$761.40M |
| Cash flow statement | ||||
| Operating cash flow | $667.50M | $1.16B | $735.00M | $225.60M |
| Capital expenditure | $13.10M | $11.70M | $9.00M | $3.60M |
| Free cash flow | $654.40M | $1.15B | $726.00M | $222.00M |
| Investing cash flow | -$264.30M | -$35.30M | -$97.60M | -$46.30M |
| Financing cash flow | -$123.90M | -$37.20M | -$72.80M | $26.50M |
| Depreciation & amortization | $36.10M | $29.50M | $27.10M | $13.80M |
| Dividends paid | $55.50M | $77.10M | $58.30M | $6.60M |
| Share buybacks | $44.10M | $19.80M | $3.10M | $7.90M |
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.